Proxalutamide (GT0918) Reduces the Rate of Hospitalization in mild-to-moderate COVID-19 Female Patients: A Randomized Double-Blinded Placebo-Controlled Two-Arm Parallel Trial

Flávio Adsuara Cadegiani, Ricardo Ariel Zimerman, Daniel do Nascimento Fonseca, Michael do Nascimento Correia, John McCoy, Carlos Gustavo Wambier, Andy Goren
doi: https://doi.org/10.1101/2021.07.06.21260086

Article usage

Article usage: July 2021 to December 2024

AbstractFullPdf
Jul 2021328927384
Aug 20213532979
Sep 20212738107
Oct 20211851237
Nov 20211721051
Dec 2021126332
Jan 2022111418
Feb 202280012
Mar 202267615
Apr 20221311172
May 20221001340
Jun 2022831934
Jul 2022751232
Aug 202281529
Sep 202278113
Oct 202258021
Nov 202257323
Dec 202267923
Jan 202331314
Feb 2023531112
Mar 202343214
Apr 202356623
May 202333212
Jun 20233149
Jul 202327814
Aug 2023431613
Sep 2023471121
Oct 2023251112
Nov 202384210
Dec 20233616
Jan 20242926
Feb 202431515
Mar 202423010
Apr 202423816
May 20243497
Jun 202431412
Jul 202420711
Aug 2024321411
Sep 20244349
Oct 20242878
Nov 202433214
Dec 20241313
Back to top
Posted July 10, 2021.
Download PDF
Data/Code
Email
Proxalutamide (GT0918) Reduces the Rate of Hospitalization in mild-to-moderate COVID-19 Female Patients: A Randomized Double-Blinded Placebo-Controlled Two-Arm Parallel Trial
Flávio Adsuara Cadegiani, Ricardo Ariel Zimerman, Daniel do Nascimento Fonseca, Michael do Nascimento Correia, John McCoy, Carlos Gustavo Wambier, Andy Goren
medRxiv 2021.07.06.21260086; doi: https://doi.org/10.1101/2021.07.06.21260086
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area